DE2009343C3 - Verwendung von Lysolecithinen als immunologische Adjuvantien - Google Patents

Verwendung von Lysolecithinen als immunologische Adjuvantien

Info

Publication number
DE2009343C3
DE2009343C3 DE2009343A DE2009343A DE2009343C3 DE 2009343 C3 DE2009343 C3 DE 2009343C3 DE 2009343 A DE2009343 A DE 2009343A DE 2009343 A DE2009343 A DE 2009343A DE 2009343 C3 DE2009343 C3 DE 2009343C3
Authority
DE
Germany
Prior art keywords
lysolecithins
acyl
bgg
immunological adjuvants
adjuvants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2009343A
Other languages
German (de)
English (en)
Other versions
DE2009343B2 (de
DE2009343A1 (de
Inventor
Beantragt Nichtennung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Original Assignee
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft zur Foerderung der Wissenschaften eV filed Critical Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Priority to DE2009343A priority Critical patent/DE2009343C3/de
Priority to NL7102368A priority patent/NL7102368A/xx
Priority to US00118084A priority patent/US3752886A/en
Priority to FR7106704A priority patent/FR2081547B1/fr
Priority to BE763580A priority patent/BE763580A/xx
Priority to ZA711242A priority patent/ZA711242B/xx
Priority to GB2435971*A priority patent/GB1334138A/en
Publication of DE2009343A1 publication Critical patent/DE2009343A1/de
Publication of DE2009343B2 publication Critical patent/DE2009343B2/de
Application granted granted Critical
Publication of DE2009343C3 publication Critical patent/DE2009343C3/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE2009343A 1970-02-27 1970-02-27 Verwendung von Lysolecithinen als immunologische Adjuvantien Expired DE2009343C3 (de)

Priority Applications (7)

Application Number Priority Date Filing Date Title
DE2009343A DE2009343C3 (de) 1970-02-27 1970-02-27 Verwendung von Lysolecithinen als immunologische Adjuvantien
US00118084A US3752886A (en) 1970-02-27 1971-02-23 Lysolecithins as immunologic adjuvants
NL7102368A NL7102368A (OSRAM) 1970-02-27 1971-02-23
BE763580A BE763580A (fr) 1970-02-27 1971-02-26 Utilisation de lysolecithines comme adjuvants immunologiques
FR7106704A FR2081547B1 (OSRAM) 1970-02-27 1971-02-26
ZA711242A ZA711242B (en) 1970-02-27 1971-02-26 Use of lysolecithins as immunological adjuvants
GB2435971*A GB1334138A (en) 1970-02-27 1971-04-19 Immunological adjuvatns

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2009343A DE2009343C3 (de) 1970-02-27 1970-02-27 Verwendung von Lysolecithinen als immunologische Adjuvantien

Publications (3)

Publication Number Publication Date
DE2009343A1 DE2009343A1 (de) 1971-09-02
DE2009343B2 DE2009343B2 (de) 1980-02-28
DE2009343C3 true DE2009343C3 (de) 1980-10-23

Family

ID=5763599

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2009343A Expired DE2009343C3 (de) 1970-02-27 1970-02-27 Verwendung von Lysolecithinen als immunologische Adjuvantien

Country Status (7)

Country Link
US (1) US3752886A (OSRAM)
BE (1) BE763580A (OSRAM)
DE (1) DE2009343C3 (OSRAM)
FR (1) FR2081547B1 (OSRAM)
GB (1) GB1334138A (OSRAM)
NL (1) NL7102368A (OSRAM)
ZA (1) ZA711242B (OSRAM)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1502774A (en) * 1974-06-25 1978-03-01 Nat Res Dev Immunological preparations
DE2619686C2 (de) * 1976-05-04 1986-08-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verwendung eines Lysolecithins zur Tumorbehandlung
GB2046092B (en) * 1979-03-05 1983-11-02 Toyama Chemical Co Ltd Pharmaceutical composition containing a lysophospholid and a phospholipid
US4439199A (en) * 1980-02-19 1984-03-27 Alza Corporation Method for administering immunopotentiator
US4455142A (en) * 1980-07-07 1984-06-19 Alza Corporation Method of coadministering an antigen and an immunopotentiator
US4484923A (en) * 1982-03-25 1984-11-27 Alza Corporation Method for administering immunopotentiator
US4666893A (en) * 1983-02-15 1987-05-19 St. Thomas Institute Methods of inducing resistance to bacterial and viral infections
JPS6045518A (ja) * 1983-08-22 1985-03-12 Takeda Chem Ind Ltd 抗シヨツク剤
US4923854A (en) * 1986-01-22 1990-05-08 The Liposome Company, Inc. Solubilization of hydrophobic materials using lysophospholipid
US5084269A (en) * 1986-11-06 1992-01-28 Kullenberg Fred W Adjuvant for dose treatment with antigens
DE3918082A1 (de) * 1989-06-02 1991-01-24 Max Planck Gesellschaft Mittel gegen autoimmunerkrankungen
IE912535A1 (en) * 1990-07-27 1992-01-29 Res Dev Foundation Liposomes that Provide Thymic Dependent Help to Weak Vaccine¹Antigens
CA2092731A1 (en) * 1993-03-26 1994-09-27 Yaping Shen Mirror amide cord factors and mirror thioesther cord factors for diagnosis of tuberculosis
WO1996011670A1 (en) * 1994-10-14 1996-04-25 The Liposome Company, Inc. Ether lipid liposomes and their therapeutic use
USRE39042E1 (en) * 1996-02-16 2006-03-28 The Liposome Company, Inc. Etherlipid-containing multiple lipid liposomes
US6007839A (en) * 1996-02-16 1999-12-28 The Liposome Company, Inc. Preparation of pharmaceutical compositions containing etherlipid-containing multiple lipid liposomes
US5942246A (en) * 1996-02-16 1999-08-24 The Liposome Company, Inc. Etherlipid containing multiple lipid liposomes
US5965159A (en) * 1996-02-16 1999-10-12 The Liposome Company, Inc. Etherlipid-containing multiple lipid liposomes
US6667053B1 (en) 1996-02-16 2003-12-23 Elan Pharmaceuticals, Inc. D and L etherlipid stereoisomers and liposomes
US5932242A (en) * 1996-10-15 1999-08-03 The Liposome Company, Inc. Ether lipid-containing pharmaceutical compositions and therapeutic uses thereof

Also Published As

Publication number Publication date
FR2081547B1 (OSRAM) 1974-03-22
FR2081547A1 (OSRAM) 1971-12-03
GB1334138A (en) 1973-10-17
DE2009343B2 (de) 1980-02-28
US3752886A (en) 1973-08-14
ZA711242B (en) 1971-12-29
DE2009343A1 (de) 1971-09-02
BE763580A (fr) 1971-08-26
NL7102368A (OSRAM) 1971-08-31

Similar Documents

Publication Publication Date Title
DE2009343C3 (de) Verwendung von Lysolecithinen als immunologische Adjuvantien
DE2009341C3 (de) 3-Octadecyloxy-propanol-(l)-phosphorsäure-monocholinester und Verfahren zu dessen Herstellung
Brandt et al. Ornithine decarboxylase activity and polyamine synthesis during kidney hypertrophy
DE2202441B2 (de) Barbitursäureantigene und spezifische Antikörper hierfür
Williams et al. The further fractionation of yeast nutrilites and their relationship to vitamin B and Wildiers'“bios”
CH414061A (de) Verfahren zur Herstellung eines Impfstoffes gegen Masern
DE2009342C3 (de) Verwendung von Glycerin-alkyläther-(l)-phosphorsäure-(3)-monocholinestern
DE2152112C3 (de) Impfstoff gegen Pseudomonas aeruginosa
Roe et al. Thalidomide and neoplasia
DE2408724A1 (de) Biologische extrakte und verfahren zu ihrer herstellung
Orimo Further Report on Glyoxalase Content in Human Milk and Arakawa's Reaction 108th Report of the Peroxidase Reaction
DE68924265T2 (de) Verwendung von einem reagens zum nachweis eines mit einem säurebeständigen bakterienantigen übereinstimmenden antikörpers.
DE2644149C3 (de) Neue Parasiten-Antigene
DE2728802C2 (de) Verfahren zum Herstellen eines antischistosomen immunologischen Mittels
Khuller et al. Immunological studies with sulpholipids of mycqbacteria
DE1768985B2 (de) Verfahren zur Herstellung von optisch aktiven Steroid-Verbindungen, die einen am 13 ß -Kohlenstoffatom (C, bis C4 )alkylsubstituierten 17-Hydroxy-8, 14-secogona-polyen- 14-on-kern enthalten
DE2925345C2 (de) N[β-(2-Mercaptoäthylcarbamoyl)-äthyl]-phenoxyalkansäureamide, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
DE2220053C3 (de) Mittel zur aktiven und passiven Immunisierung gegen die toxischen Effekte von Infektionen durch Elastase bildende Bakterien und Verfahren zur Herstellung derselben
Abdel Kader et al. The effect of indole derivatives on Mycobacterium tuberculosis
Osman Experimental Immunization with Bacteria Detoxicated by Gold Chloride
Holme et al. Antigens of spheroplast membrane preparations from Escherichia coli B
DE2265620C2 (de) Mittel zur passiven Immunisierung gegen die toxischen Effekte von Infektionen durch Elastase bildende Bakterien und Verfahren zur Herstellung desselben
Yamamura et al. Studies on the Virulence of Tubercle Bacilli Using P32-labeled Bacilli: I. The Comparison of Elimination in Vivo of P32 Derived from Heat-killed Virulent and Avirulent Tubercle Bacilli
DE424188C (de) Verfahren zur Herstellung eines Heilserums gegen Krebsgeschwuelste u. dgl.
US1250345A (en) Substance for treatment of tuberculosis, leprosy, and other diseases and process of mixing said substance.

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
8339 Ceased/non-payment of the annual fee